Point72 (DIFC)’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$11.7K	Buy	+10,465	New	+$11.7K	﹤0.01%	741
2025 Q1	–	Sell	-31,682	Closed	-$52.3K	–	1152
2024 Q4	$52.3K	Buy	+31,682	New	+$52.3K	﹤0.01%	571